Adjunctive dexamethasone therapy for pediatric bacterial meningitis

Journal of Emergency Medicine

Volumn 14, Issue 2, 1996, Pages 165-172

  Bonadio, William A ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b NONE   (United States)

Author keywords

antibiotics; bacterial meningitis; corticosteroids; infectious diseases; neurologic sequelae

Indexed keywords

CEFOTAXIME; CEFTRIAXONE; CORTICOSTEROID; DEXAMETHASONE; INTERLEUKIN 1BETA; PHOSPHOLIPASE A2; PROSTAGLANDIN E2; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIAL MENINGITIS; CLINICAL TRIAL; DOSE TIME EFFECT RELATION; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN TISSUE; META ANALYSIS; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; STEROID THERAPY; TREATMENT OUTCOME;

EID: 0029925570     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/0736-4679(95)02104-3     Document Type: Article

References (40)

1. Klein J, Feigin R, McCracken G. Report of the Task Force on Diagnosis and Management of Meningitis. Pediatr Infect Dis J. 1993; 12:31-42.
2. Taylor H, Mills E, Ciampi A, et al. The sequelae of Haemophilus influenzae meningitis in school-aged children. N Engl J Med. 1990; 323:1657-63.
3. Lebel M, Hoyt M, McCracken G, et al. Comparative efficacy of ceftriaxone and cefuroxime for treatment of bacterial meningitis. J Pediatr. 1989; 114:1049-54.
4. Schaad U, Suter S, Gianella B, et al. A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis of infants and children. N Engl J Med. 1990;322:141-7.
5. Schoendorf K, Adams W, Kiely J, Wenger JL. National trends in Haemophilus influenzae meningitis mortality and hospitalization among children, 1980 through 1991. Pediatrics. 1994; 93:663-8.
6. Waagner D, Kennedy W, Hoyt M, et al. Timing of dexamethasone therapy for bacterial meningitis. (Abstract 1096) Pediatr Res. 1990;27(4, part 2):185A.
7. Syrogiannopoulos G, Lourida A, Theodoridou M, et al. Dexamethasone therapy for bacterial meningitis in children: 2 vs. 4 day regimen. J Infect Dis. 1994; 169:853-8.
8. Lebel M, Freij B, Syrogiannipoulos G, et al. Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials. N Engl J Med. 1988;319:964-71.
9. Odio C, Faingezicht I, Paris M, et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med. 1991;324:1525-31.
10. Schaad U, Lips U, Gnehm H, et al. Dexamethasone therapy for bacterial meningitis in children. Lancet. 1993; 342:457-61.
11. Wald E, Kaplan S, Mason E, et al. Dexamethasone therapy for children with bacterial meningitis. Pediatrics. 1995;95:21-8.
12. Girgis N, Farid Z, Mikhail I, et al Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr Infect Dis J. 1989;8:848-51.
13. Lebel M, Hoyt M, Waagner D, et al. Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis. Am J Dis Child. 1989; 143:301-6.
14. Kennedy W, Hoyt M, McCracken G. The role of corticosteroid therapy in children with pneumococcal meningitis. Am J Dis Child. 1991; 145:1374-8.
15. Leist T, Frei K, Hansen S, Zinkernagel R, Fontana A. Tumor necrosis factor alpha in cerebrospinal fluid during bacterial but not viral meningitis: evaluation in murine model infections and in patients. J Exp Med. 1988; 167:1743-8.
16. Tauber M, Shibi A, Haekbarth C, et al. Antibiotic therapy, endotoxin concentration in cerebrospinal fluid and brain edema in experimental Escherichia coli meningitis in rabbits. J Infect Dis. 1987; 156:456-462.
17. Tuomanen E, Hengstler B, Rich R, et al. Nonsteroidal antiinflammatory agents in the therapy of experimental pneumococcal meningitis. J Infect Dis. 1987; 155:985-90.
18. Mustafa M, Ramilo O, Saez-Llorens X, et al. Cerebrospinal fluid prostaglandins, interleukin 1 beta, and tumor necrosis factor in bacterial meningitis: clinical and laboratory correlations in placebo and dexamethasone-treated patients. Am J Dis Child. 1990; 144:883-7.
19. Ramilo O, Saez-Llorens X, Mertsola J, et al. Tumor necrosis factor alpha/cachectic and interleukin 1 beta initiate meningeal inflammation. J Exp Med. 1990; 172:497-507.
20. Saukkonen K, Sande S, Cioffe C, et al. The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J Exp Med. 1990; 171:439-48.
21. Tureen J, Dworkin R, Kennedy S, Sachdeva M, Sande W. Loss of cerebrovascular autoregulation in experimental meningitis in rabbits. J Clin Invest. 1990;85:577-81.
22. Pfister H, Koedel U, Haben R, et al. Microvascular changes during the early phase of experimental bacterial meningitis. J Cereb Blood Flow Metab. 1990; 10:914-22.
23. Tureen J, Tauber M, Sande M. Effect of hydration status on cerebral blood flow and cerebrospinal fluid lactic acidosis in rabbits with experimental meningitis. J Clin Invest. 1992; 89:947-53.
24. Scheld W, Dacey R, Winn H, et al. Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. J Clin Invest. 1980; 66:243-53.
25. Mustafa M, Lebel M, Ramilo O, et al. Correlation of interleukin-1 beta and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. J Pediatr. 1989; 115:208-13.
26. Tauber M, Khayam H, Sande M. Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. J Infect Dis. 1985; 151:528-34.
27. Syrogiannopoulos G, Olsen K, Reisch J, McCracken G. Dexamethasone in the treatment of experimental Haemophilus influenzae type b meningitis. J Infect Dis. 1987; 155:213-9.
28. Belsey M, Hoffpauir C, Smith M. Dexamethasone in the treatment of acute bacterial meningitis: effect of study design on the interpretation of results. Pediatrics. 1969;44:503-13.
29. DeLemos R, Haggerty R. Corticosteroids as an adjunct to treatment of acute bacterial meningitis. A controlled clinic trial. Pediatrics. 1969;44:30-4.
30. Waagner D, Kennedy W, Hoyt J, et al. Lack of adverse effects of dexamethasone therapy in aseptic meningitis. Pediatr Infect Dis J. 1990;9:922-3.
31. Brieman R, Butler J, Tenover F, et al. Emergence of drug-resistant pneumococcal infections in the United States. JAMA. 1994;271:1831-5.
32. Viladrich P, Guidol F, Linares J, et al. Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob Agents Chemother. 1991; 35:2467-72.
33. Paris M, Hickey S, Uscher M, et al. Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother. 1994; 38:1320.
34. Bonadio, WA. Dexamethasone therapy for pediatric bacterial meningitis. Pediatrics. 1996;95:286-7.
35. Schoendorf K, Adams W, Kiely J, Wenger J. National trends in Haemophilus influenzae meningitis mortality and hospitalization among children, 1980 through 1991. Pediatrics. 1994; 93:663-8.
36. Bonadio, WA. Current opinion: indications for initiating dexamethasone therapy in children with meningitis in the emergency department. Am J Dis Child. 1993; 147:131.
37. Klass P, Klein J. Therapy of bacterial sepsis, meningitis and otitis media in infants and children: 1992 poll of directors of programs in pediatric infectious diseases. Pediatr Infect Dis J. 1992; 11:702-5.
38. Report of the Committee on Infectious Diseases of the American Academy of Pediatrics (22nd edn.) Dexamethasone Therapy for Bacterial Meningitis in Infants and Children. Elk Grove Village, IL: American Academy of Pediatrics 1994:558-9.
39. Bonadio WA. The cerebrospinal fluid: physiologic aspects and alterations associated with bacterial meningitis. Pediatr Infect Dis J. 1992;11:423-32.
40. Bonadio, WA. Acute bacterial meningitis and the cerebrospinal fluid differential count. Clin Pediatr. 1988;27:445-7.